| Literature DB >> 31241690 |
Belén Aneiros1, Indalecio Cano1, Araceli García1, Pedro Yuste1, Eduardo Ferrero1, Andrés Gómez1.
Abstract
OBJECTIVE: To investigate the influence of patient age on the diagnosis and management of appendicitis, as well as to evaluate the rate of complications according to the age group.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31241690 PMCID: PMC6868550 DOI: 10.1590/1984-0462/;2019;37;3;00019
Source DB: PubMed Journal: Rev Paul Pediatr ISSN: 0103-0582
Comparison of the symptoms and signs between the groups A and B.
|
Group A (n=50) |
Group B (n=233) | p-value | |
|---|---|---|---|
| Vomiting | 32 (66.7%) | 172 (74.5%) | 0.267 |
| Diarrhea | 17 (35.4%) | 35 (15.2%) | 0.001* |
| Fever | 39 (81.3%) | 136 (58.9%) | 0.009* |
| Urinary symptoms | 2 (4.2%) | 15 (6.5%) | 0.535 |
| Respiratory symptoms | 7 (14.9%) | 29 (12.7%) | 0.719 |
| Abdominal pain | |||
| Focal | 18 (39.1%) | 148 (66.7%) | 0.001* |
| Diffuse | 21 (45.7%) | 60 (27%) | |
| Ill-defined | 7 (15.2%) | 14 (6.3%) | |
| Tenderness | |||
| Focal | 11 (23%) | 85 (38.1%) | <0.001* |
| Diffuse | 17 (35.4%) | 34 (15.3%) | |
| Ill-defined | 20 (41.6%) | 104 (46.6%) | |
*Statistically significant.
Comparison of the postoperative variables between the groups A and B.
|
Group A (n=50) |
Group B (n=233) | p-value | |
|---|---|---|---|
| Antibiotic therapy (days) | 5.94 | 4.53 | 0.003* |
| Onset of oral intake (days) | 2.59 | 1.86 | 0.002* |
| Analgesic therapy (days) | 5.42 | 3.36 | 0.004* |
| Length of stay (days) | 9.38 | 6.41 | 0.006* |
| Intra-abdominal abscess | 8 (16%) | 28 (12%) | 0.443 |
| Wound infection | 0 | 7 (3%) | 0.214 |
| Bowel obstruction | 1 (2%) | 6 (2.6%) | 0.812 |
*Statistically significant.
Comparison of the symptoms and signs in the groups C and D.
|
Group C (n=1,453) |
Group D (n=283) | p-value | |
|---|---|---|---|
| Vomiting | 954 (66.2%) | 204 (73.1%) | 0.024* |
| Diarrhea | 181 (12.6%) | 52 (18.6%) | 0.007* |
| Fever | 484 (33.5%) | 175 (62.7%) | <0.001* |
| Urinary symptoms | 110 (7.6%) | 17 (6.1%) | 0.377 |
| Respiratory symptoms | 42 (2.9%) | 36 (13%) | <0.001* |
| Abdominal pain | |||
| Focal | 1,221 (84%) | 166 (58.6%) | <0.001* |
| Diffuse | 147 (10.1%) | 81 (28.6%) | |
| Ill-defined | 29 (2%) | 18 (6.4%) | |
| Doubtful | 56 (3.9%) | 18 (6.4%) | |
| Tenderness | |||
| Focal | 514 (35.4%) | 96 (34%) | <0.001* |
| Diffuse | 83 (5.7%) | 51 (18%) | |
| Ill-defined | 30 (2.1%) | 19 (6.7%) | |
| Doubtful | 826 (56.8%) | 117 (41.3%) | |
*Statistically significant.
Comparison of the postoperative outcomes and complications between the groups C and D.
|
Group C (n=1,453) |
Group D (n=283) | p-value | |
|---|---|---|---|
| Antibiotic therapy (days) | 3.17 | 4.77 | <0.001* |
| Onset of oral intake (days) | 1.39 | 1.99 | <0.001* |
| Analgesic therapy (days) | 2.39 | 3.73 | <0.001* |
| Length of stay (days) | 4.59 | 6.94 | <0.001* |
| Intra-abdominal abscess | 87 (6%) | 36 (12.7%) | <0.001* |
| Wound infection | 25 (1.7%) | 7 (2.5%) | 0.389 |
| Bowel obstruction | 19 (1.3%) | 7 (2.8) | 0.139 |
*Statistically significant.